BeiGene
id:
beigene-213-3425703
title:
BeiGene
text:
BeiGene, Ltd. is a China-based drug developer. It specializes in the development of drugs for cancer treatment. Founded in 2010 by chief executive officer John V. Oyler and Xiaodong Wang, the multinational company headquartered in Cambridge, Massachusetts has offices in North America, Europe, South America, Asia and Australia. BeiGene has a large presence in the Chinese market. BeiGene has developed several pharmaceuticals, including tislelizumab, a checkpoint inhibitor, and zanubrutinib, a Brut
brand slug:
wiki
category slug:
encyclopedia
description:
Global biotechnology company
original url:
https://en.wikipedia.org/wiki/BeiGene
date created:
2020-08-04T20:14:12Z
date modified:
2024-09-12T16:38:51Z
main entity:
{"identifier":"Q30260298","url":"https://www.wikidata.org/entity/Q30260298"}
image:
fields total:
13
integrity:
15